All News

Check out these important FDA updates from the month of May 2024.

Take a look back at the conference coverage you may have missed this month.

Roche's self-collection kit allows women to screen for cervical cancer at home, offering an alternative to a visit to a health care provider and promoting early detection of the disease.

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

The drug will be available in pharmacies during the second half of 2024.

Check out these featured Drug Topics expert interviews from May 2024.

Catch up on important continuous glucose monitoring (CGM) news from the month of May.

After 24 weeks of participation in an AI-driven lifestyle coaching program, 78% of all participants achieved a clinically meaningful SBP reduction of 5 mm Hg or greater.

Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.

Eculizamab-aeeb is the 53rd FDA-approved biosimilar in the US.

While US health officials continue to monitor the outbreak in dairy cattle across the country, a second human recently tested positive after a mutation of the bird flu virus.

Don’t miss out on the latest pharmacy insights in the Drug Topics May issue.

Emergency department visits tripled by December 2022 compared with the pre-legalization period from January 2015 to September 2018.

A recent study found that if community pharmacists were utilized to treat common conditions, it could result in significant cost-savings for the health care system.

Check out these top featured stories from Drug Topics in May 2024.

Research exploring the growing role of artificial intelligence (AI) in health care sheds a light on the potential of the technology to improve skin cancer detection and awareness among patients and health care professionals.

To assess the extent of FTC regulation, researchers collected data from the group’s merger and enforcement actions in a 22-year span.

In case you missed it, this week we had news about student-athlete suicides, the benefits of omega-3, the rise in tianeptine across the US, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Check out important updates from the FDA for the week of May 20.

Experienced litigation lawyer Mark Cuker sat down with Drug Topics to discuss pharmacy benefit managers and their often corrupt practices.

Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.

In an abstract presented at Digestive Disease Week 2024, researchers analyzed Clostridioides difficile episodes and identified the risk factors and potential medications that caused them.

Recent research on food allergy highlights the mental health concerns of people living with a food allergy, how nutritional intervention can help children with food allergy, and that peanut introduction can reduce rates of new allergy in high-risk infants.

During a May 16 hearing titled “Rural Health Care: Supporting Lives and Improving Communities,” members discussed the need for better health care resources among rural communities in the US.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, discusses what tianeptine is and how pharmacists can help warn the public about its potential hazards.

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

Test your knowledge of asthma and allergy triggers.